AstraZeneca PLC Capital Reinvestment Ratio
AstraZeneca PLC capital reinvestment ratio. AstraZeneca PLC (AZN) has a Capital Reinvestment Ratio of 0.46x as of March 2026, meaning it reinvests 0% of its operating cash flow ($3.36 Billion) in capital expenditures ($1.54 Billion). See AZN free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of AstraZeneca PLC (1990–2025)
Capital reinvestment ratio of AstraZeneca PLC from 1990 to 2025. This chart tracks AstraZeneca PLC's Capital Reinvestment Ratio across 36 annual periods. See AZN financial flexibility score to measure the company's free cash flow as a share of total liabilities.
AstraZeneca PLC Capital Reinvestment Ratio by Year (1990–2025)
AstraZeneca PLC capital reinvestment ratio by year from 1990 to 2025. For the full cash flow conversion analysis, see cash flow conversion of AstraZeneca PLC.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | $14.57 Billion | $2.81 Billion | ▼ -50.1% |
| 2024 | 0.39x | $11.86 Billion | $4.59 Billion | ▲ +5.9% |
| 2023 | 0.37x | $10.35 Billion | $3.78 Billion | ▲ +39.3% |
| 2022 | 0.26x | $9.81 Billion | $2.57 Billion | ▼ -29.0% |
| 2021 | 0.37x | $5.96 Billion | $2.20 Billion | ▼ -32.1% |
| 2020 | 0.54x | $4.80 Billion | $2.61 Billion | ▼ -34.5% |
| 2019 | 0.83x | $2.97 Billion | $2.46 Billion | ▲ +58.2% |
| 2018 | 0.52x | $2.62 Billion | $1.37 Billion | ▲ +15.7% |
| 2017 | 0.45x | $3.58 Billion | $1.62 Billion | ▼ -18.9% |
| 2016 | 0.56x | $4.14 Billion | $2.31 Billion | ▼ -33.4% |
| 2015 | 0.84x | $3.32 Billion | $2.79 Billion | ▲ +115.1% |
| 2014 | 0.39x | $7.06 Billion | $2.75 Billion | ▲ +40.2% |
| 2013 | 0.28x | $7.40 Billion | $2.06 Billion | ▼ -58.2% |
| 2012 | 0.66x | $6.95 Billion | $4.62 Billion | ▲ +300.9% |
| 2011 | 0.17x | $7.82 Billion | $1.30 Billion | ▼ -26.8% |
| 2010 | 0.23x | $10.68 Billion | $2.42 Billion | ▼ -10.0% |
| 2009 | 0.25x | $11.74 Billion | $2.96 Billion | ▼ -45.5% |
| 2008 | 0.46x | $8.74 Billion | $4.04 Billion | ▲ +106.7% |
| 2007 | 0.22x | $7.51 Billion | $1.68 Billion | ▲ +28.4% |
| 2006 | 0.17x | $7.69 Billion | $1.34 Billion | ▲ +19.9% |
| 2005 | 0.15x | $6.74 Billion | $979.00 Million | ▲ +113.1% |
| 2004 | 0.07x | $4.87 Billion | $332.00 Million | ▼ -81.8% |
| 2003 | 0.38x | $3.42 Billion | $1.28 Billion | ▲ +35.4% |
| 2002 | 0.28x | $4.83 Billion | $1.34 Billion | ▼ -66.8% |
| 2001 | 0.84x | $2.71 Billion | $2.26 Billion | ▲ +33.7% |
| 2000 | 0.63x | $2.34 Billion | $1.46 Billion | ▼ -79.4% |
| 1999 | 3.03x | $908.55 Million | $2.75 Billion | ▲ +215.4% |
| 1998 | 0.96x | $879.74 Million | $844.88 Million | ▼ -5.0% |
| 1997 | 1.01x | $747.21 Million | $755.47 Million | ▲ +24.7% |
| 1996 | 0.81x | $787.75 Million | $638.76 Million | ▲ +10.2% |
| 1995 | 0.74x | $585.64 Million | $431.11 Million | ▼ -6.5% |
| 1994 | 0.79x | $625.36 Million | $492.47 Million | ▲ +20.0% |
| 1993 | 0.66x | $705.58 Million | $462.99 Million | ▼ -66.7% |
| 1992 | 1.97x | $206.27 Million | $406.47 Million | ▲ +158.3% |
| 1991 | 0.76x | $505.22 Million | $385.46 Million | ▲ +13.9% |
| 1990 | 0.67x | $806.30 Million | $540.10 Million | — |